Liquidia Technologies, Inc. (NASDAQ:LQDA) CEO Roger Jeffs Sells 20,252 Shares

Liquidia Technologies, Inc. (NASDAQ:LQDA - Get Free Report) CEO Roger Jeffs sold 20,252 shares of the firm's stock in a transaction on Monday, July 14th. The stock was sold at an average price of $14.28, for a total transaction of $289,198.56. Following the completion of the sale, the chief executive officer directly owned 1,038,560 shares in the company, valued at approximately $14,830,636.80. This trade represents a 1.91% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Liquidia Technologies Price Performance

LQDA stock traded up $0.03 during trading on Tuesday, hitting $14.51. 1,205,334 shares of the company's stock traded hands, compared to its average volume of 1,304,306. Liquidia Technologies, Inc. has a 52 week low of $8.26 and a 52 week high of $19.41. The stock has a market capitalization of $1.24 billion, a price-to-earnings ratio of -9.18 and a beta of -0.01. The business has a fifty day simple moving average of $14.97 and a 200 day simple moving average of $14.44. The company has a debt-to-equity ratio of 2.08, a quick ratio of 2.91 and a current ratio of 2.93.

Liquidia Technologies (NASDAQ:LQDA - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The company reported ($0.45) EPS for the quarter, missing analysts' consensus estimates of ($0.42) by ($0.03). The business had revenue of $3.12 million during the quarter, compared to the consensus estimate of $3.23 million. Liquidia Technologies had a negative net margin of 903.80% and a negative return on equity of 177.91%. As a group, research analysts expect that Liquidia Technologies, Inc. will post -1.51 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the stock. Needham & Company LLC restated a "buy" rating on shares of Liquidia Technologies in a report on Monday, June 2nd. Raymond James Financial upped their target price on shares of Liquidia Technologies from $27.00 to $29.00 and gave the company a "strong-buy" rating in a report on Friday, May 9th. Wall Street Zen upgraded Liquidia Technologies from a "sell" rating to a "hold" rating in a research note on Thursday, May 22nd. Wells Fargo & Company raised their target price on shares of Liquidia Technologies from $23.00 to $25.00 and gave the stock an "overweight" rating in a research note on Thursday, June 12th. Finally, Scotiabank upped their target price on shares of Liquidia Technologies from $36.00 to $37.00 and gave the stock a "sector outperform" rating in a report on Wednesday, May 28th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, six have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, Liquidia Technologies presently has a consensus rating of "Moderate Buy" and an average target price of $26.89.

Hedge Funds Weigh In On Liquidia Technologies

Large investors have recently made changes to their positions in the company. Cetera Investment Advisers boosted its stake in shares of Liquidia Technologies by 4.3% during the fourth quarter. Cetera Investment Advisers now owns 31,243 shares of the company's stock valued at $367,000 after purchasing an additional 1,277 shares in the last quarter. Deutsche Bank AG increased its holdings in shares of Liquidia Technologies by 53.4% in the 4th quarter. Deutsche Bank AG now owns 51,075 shares of the company's stock valued at $601,000 after acquiring an additional 17,790 shares during the period. Raymond James Financial Inc. bought a new position in shares of Liquidia Technologies in the 4th quarter worth $218,000. Millennium Management LLC bought a new stake in Liquidia Technologies during the fourth quarter valued at about $526,000. Finally, Charles Schwab Investment Management Inc. grew its stake in Liquidia Technologies by 9.8% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 428,570 shares of the company's stock valued at $5,040,000 after purchasing an additional 38,313 shares during the last quarter. 64.54% of the stock is owned by hedge funds and other institutional investors.

About Liquidia Technologies

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.